Publication Name	World Journal of Clinical Oncology
Manuscript ID	90414
Country	Türkiye

Received	2023-12-03 11:37
Peer-Review Started	2023-12-03 11:37
To Make the First Decision
Return for Revision	2023-12-07 03:12
Revised	2023-12-16 10:53
Second Decision	2024-01-09 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-09 05:35
Articles in Press	2024-01-09 05:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-06 08:16
Publish the Manuscript Online	2024-02-20 08:53

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Circulating tumor cells as prognostic marker in pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Melek Yakar and Durmuş Etiz
Funding Agency and Grant Number
Corresponding Author	Melek Yakar, MD, Adjunct Associate Professor, Department of Radiation Oncology, Osmangazi University, Meşelik Campus Büyükdere District Prof. Dr. Nabi AVCI Boulevard No. 4 26040 Odunpazarı, Eskişehir 26040, Türkiye. myakar@ogu.edu.tr
Key Words	Pancreatic cancer; Circulating tumor cells; Prognosis; Biomarkers; Overall survival
Core Tip	Pancreatic cancer is a cancer that is usually diagnosed at an advanced stage due to its late onset of symptoms and rapid progression, and therefore has a high mortality rate despite intensive treatments. Detecting patients at an earlier stage is important in terms of cure rates. Predicting occult metastases in radiologically resectable cases will prevent unnecessary surgery. Additionally, if the patient's prognosis can be predicted, different treatment strategies and even personalized treatments may come to the fore. Currently, there is no reliable biomarker for diagnosis, staging or prognosis prediction in pancreatic cancer. Circulating tumor cells are promising in this respect.
Publish Date	2024-02-20 08:53
Citation	Yakar M, Etiz D. Circulating tumor cells as prognostic marker in pancreatic cancer. World J Clin Oncol 2024; 15(2): 165-168
URL	https://www.wjgnet.com/2218-4333/full/v15/i2/165.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i2.165

Full Article (PDF)	WJCO-15-165-with-cover.pdf
Full Article (Word)	WJCO-15-165.docx
Manuscript File	90414_Auto_Edited-LJH-YJP.docx
Answering Reviewers	90414-Answering reviewers.pdf
Audio Core Tip	90414-Audio core tip.aac
Conflict-of-Interest Disclosure Form	90414-Conflict-of-interest statement.pdf
Copyright License Agreement	90414-Copyright license agreement.pdf
Peer-review Report	90414-Peer-review(s).pdf
Scientific Misconduct Check	90414-Bing-Liu JH-2.png
Scientific Misconduct Check	90414-CrossCheck.png
Scientific Editor Work List	90414-Scientific editor work list.pdf